Vident Advisory, LLC Grifols Sa Transaction History
Vident Advisory, LLC
- $10.5 Trillion
- Q3 2025
A detailed history of Vident Advisory, LLC transactions in Grifols Sa stock. As of the latest transaction made, Vident Advisory, LLC holds 69,519 shares of GRFS stock, worth $605,510. This represents 0.01% of its overall portfolio holdings.
Number of Shares
69,519
Previous 65,481
6.17%
Holding current value
$605,510
Previous $592 Million
16.97%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding GRFS
# of Institutions
200Shares Held
148MCall Options Held
76.1KPut Options Held
58.2K-
Brandes Investment Partners, LP La Jolla, CA29.1MShares$254 Million2.44% of portfolio
-
Capital World Investors Los Angeles, CA22.9MShares$200 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY17.5MShares$152 Million27.86% of portfolio
-
Black Creek Investment Management Inc. Toronto, A610MShares$87.5 Million5.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.94MShares$60.4 Million0.03% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.91B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...